New coverage highlights how large language models are being applied to biology and chemistry research using the growing availability of large molecular and experimental datasets. The article frames LLMs as becoming embedded across computational discovery workflows, linking structure, synthesis, and biological interpretation more tightly than prior tools. While the piece is high-level rather than describing a single regulatory or clinical milestone, it reflects how computational platforms are shifting from supporting tasks to actively shaping research decisions. That includes accelerating hypothesis generation and enabling faster iteration over chemical and biological design spaces. Biotech teams are increasingly factoring model-driven tooling into early discovery pipelines, especially in areas where experimental cycles are slow and expensive. The development matters for industry because it points to practical integration—data pipelines, model selection, and workflow automation—as the new gating factor for maintaining speed in R&D.